Infliximab
Brand name: Remicade
Rank #381 of 500 drugs by total cost
Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026
$25.3M
Total Cost
3,457
Total Claims
$25.3M
Total Cost
164
Prescribers
$7,316
Cost per Claim
154
Beneficiaries
4,534
30-Day Fills
$154K
Avg Cost/Provider
21
Avg Claims/Provider
Share of Medicare Part D Spending
0.01%
of total Medicare Part D spending
$25.3M of $275.65B
Top Prescribers by Cost
Top 10 prescribers of $25.3M total
🔎 Data Overview
At $7,316 per prescription, this is a high-cost medication. Expensive drugs drive Medicare spending growth and create access challenges for patients with coverage gaps.
Average cost of $154,221 per prescriber suggests this drug may be concentrated among specialists. High per-provider spending can sometimes indicate inappropriate prescribing or overly aggressive use.
Average cost of $164,235 per patient per year. Medications at this price point significantly impact patient out-of-pocket costs and Medicare spending.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Top Prescribers of Infliximab
| # | Provider | Specialty | Location | Claims | Cost |
|---|---|---|---|---|---|
| 1 | Gerald Ho | Rheumatology | La Palma, CA | 223 | $1.2M |
| 2 | Guillermo Valenzuela | Rheumatology | Plantation, FL | 154 | $900K |
| 3 | Vijay Singh | Rheumatology | Sewell, NJ | 107 | $895K |
| 4 | Rita Pichardo | Dermatology | Winston Salem, NC | 59 | $666K |
| 5 | Rebecca Kissel | Dermatology | Birmingham, AL | 39 | $566K |
| 6 | Noah Goldfarb | Dermatology | Minneapolis, MN | 11 | $538K |
| 7 | Christopher Sayed | Dermatology | Chapel Hill, NC | 37 | $499K |
| 8 | Babak Zamiri | Rheumatology | Riverside, CA | 81 | $411K |
| 9 | Stephen Anesi | Ophthalmology | Waltham, MA | 64 | $410K |
| 10 | Barry Resnik | Dermatology | Aventura, FL | 31 | $362K |
| 11 | Jacqueline Vo | Rheumatology | Houston, TX | 60 | $362K |
| 12 | Robert Smith | Dermatology | Baltimore, MD | 30 | $341K |
| 13 | Mark Lazarev | Gastroenterology | Baltimore, MD | 36 | $318K |
| 14 | Kirk Russ | Gastroenterology | Birmingham, AL | 24 | $303K |
| 15 | Frederick Weber | Gastroenterology | Birmingham, AL | 31 | $300K |
Top prescribers ranked by total cost for this drug in 2023.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 378 | Ponatinib Hcl (Iclusig) | $25.6M | 1,209 |
| 379 | Citalopram Hydrobromide (Citalopram Hbr) | $25.3M | 2,778,255 |
| 380 | Amoxicillin/Potassium Clav (Amoxicillin-Clavulanate Potass) | $25.3M | 2,207,997 |
| 381 | Infliximab (Remicade) | $25.3M | 3,457 |
| 382 | Glimepiride (Glimepiride) | $25.3M | 1,885,737 |
| 383 | Flecainide Acetate (Flecainide Acetate) | $25.1M | 412,334 |
| 384 | Pioglitazone Hcl (Pioglitazone Hcl) | $24.8M | 1,182,614 |
Related Analysis
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology